Introduction
The epidemic of HIV in Bangladesh is largely being driven by the people who inject drugs (PWID) and is mainly concentrated in Dhaka city. According to the data of the HIV surveillance from 2016, the prevalence of HIV among the PWID in Dhaka city has risen to an alarming situation. In Dhaka city, the prevalence of HIV significantly increased to 22.0% in 2016 from 5.3% in 2011 [1]. Data from the 2016 HIV surveillance also showed that among those PWID who were HIV positive, approximately 30% were married. A considerable percentage (35%-84%) of the HIV positive PWID had sex with wives/female sex workers (FSWs)/non-transactional female sex partners (girlfriends/relatives/neighbours) in the last year. Condom use with female sex partners was very low; only 25%-40% PWID reported that condoms were used consistently in all sex acts in the last one year prior to the HIV surveillance in 2016. This data highlights that female sex partners of the HIV positive PWID in Dhaka city are at great risk of HIV infection.
In Bangladesh, there is no data on the prevalence of HIV, risk behaviours and vulnerabilities among females who have sex particularly with the HIV positive PWID, and no comprehensive HIV prevention services in place for them. Therefore, to design or strengthen HIV prevention services for female sex partners of the HIV positive PWID, a cross-sectional study was conducted in Dhaka city in 2019 using mixed methods (qualitative and quantitative) approaches in 2019, to measure the prevalence of HIV, risk behaviours, vulnerabilities and collect information about the availability of HIV prevention services for these population groups.
Research design and methods
Study type
This study was conducted following a cross-sectional design using mixed methods (qualitative and quantitative) approach among female sex partners of the HIV positive PWID in Dhaka city.
Study population
Female sex partners were categorised into three groups who are referred to as study participants in this study, such as Group-1: wives, Group-2: FSWs, and Group-3: non-transactional/other female sex partners (except wives and FSWs such as girl-friends/relatives/neighbours) of the HIV positive PWID who receive services from 14 comprehensive drop-in-centres (CDICs)/drop-in-centres (DICs) in Dhaka city. The inclusion criteria for the participants were those who were wives of the HIV positive PWID and those who were FSWs or other female sex partners and had sex with a HIV positive PWID in the last one year prior to the survey and, willing to provide informed written consent/assent to test HIV and to provide risk behavioural information.
Sample size
Before calculating the sample size for the quantitative survey, we performed a literature review to find out the prevalence of HIV among female sex partners of the PWID in other countries. We found nine studies. The countries include: India [2, 3], Pakistan [4], Vietnam [5], Kazakhstan [6], Iran [7], Kyrgyzstan [8], Russia [9] and Malaysia [10]. The data showed that the prevalence of HIV among the female sex partners of PWID ranges from 2.5%-45.0% in these countries, thus indicating the wide variation of estimates. Using the standard formula mentioned below and the prevalence of HIV among the female sex partners of PWID from the above-mentioned countries, the calculated sample sizes ranged between 37–380. At the same time, there is no such data in Bangladesh. However, in Bangladesh we had data on the prevalence of HIV among PWID from the IBBS that was conducted in Dhaka in 2016 [1]. Due to the lack of required data in Bangladesh, we assumed that the prevalence of HIV among PWID would be equal to the prevalence of HIV among their female sex partners. Then, in order to conduct a cross-sectional study among female sex partners of the HIV positive PWID, we calculated three indicators from the IBBS dataset using Stata that are described below.
The indicators and the estimated percentage values were as follows:
1. Indicator for Group-1 (wives): Prevalence of HIV among those male PWID who were currently married = 20.7%
2. Indicator for Group-2 (FSWs): Prevalence of HIV among those male PWID who bought sex from FSWs in the last 12 months = 28.8%
3. Indicator for Group-3 (girlfriends/relatives/neighbours): Prevalence of HIV among those male PWID who had sex with non-transactional females (except FSWs and wives) in the last 12 months = 21.3%
Thereafter, to calculate the sample size for each of the groups mentioned above the following formula-1 [11] was used.
In the above equation:
n1 = Calculated sample size
p = Percentage values of the indicators from four groups of the male PWID mentioned above
q = 1-p
Z1-α/2 = The Z-score corresponding to the desired level of significance = 1.96 (at the 95% confidence interval)
d = Desired level of precision = 5%
The sample size was calculated for each of the indicators and a total of 825 (252 for Group-1, 30.6% of the total sample size; 315 for Group-2, 38.2% of the total sample size; 258 for Group-3, 31.2% of the total sample size) was calculated. Since the total number of the HIV positive male PWID who were currently alive and enlisted in the DICs in Dhaka city while the proposal of this study was being prepared was already known beforehand, the total sample size was further adjusted for the finite population correction (FPC) according to the following formula below [12], thus providing an achievable sample size.
In the above equation:
n2 = Calculated sample size after FPC and adjusting for drop-outs during risk behaviour interview
N = Total number of the HIV positive male PWID live in Dhaka city = 619 [13]
After adjusting the total sample size with FPC, the total sample size was 354. Using the proportionate percentage points of sample sizes mentioned above, the sample size for group-1 became 108 wives, 135 for FSWs and 111 for other female sex partners. Finally, the sample size was inflated by 5% to adjust for drop out during risk behaviour interview that resulted in 114 wives in Group-1, 142 FSWs in Group-2 and 116 non-transactional female sex partners in Group-3. This amounted to a total target sample size of 372 female sex partners of the HIV-positive PWID for this study.
Sampling
At the beginning of the study, to make a sampling frame of female sex partners, a mapping exercise of the HIV positive PWID was conducted in Dhaka city who were the only gatekeepers for accessing to the participants. They were asked whether or not they want to allow their female sex partners (wives, FSWs and others) to take part in this study. During this process, a total of 411 HIV positive PWID were contacted. Of them, 158 agreed that they will allow us to access to their wives, 69 of them agreed that they will allow us to access to FSWs and 9 agreed that they will allow us to access to non-transactional female sex partners. Thus, a total of 236 female sex partners of the HIV positive PWID were expected to be included in the study. Detailed addresses of the HIV positive PWID were listed, which constituted the sampling frame of female sex partners. Thereafter, the total number of female sex partners counted during mapping was compared with the target sample sizes. Since the number of female sex partners counted during mapping was smaller particularly for FSWs and other female sex partners, a take-all sampling approach was adopted to collect quantitative data for all groups. Finally, the quantitative survey was conducted among 227 participants adopting a take-all sampling technique to assess their risk behaviours, vulnerabilities and to determine HIV status. In the recruitment of participants, we have leveraged all of their network sources such as staff members from the CDIC/DIC, case workers (who provide services to the HIV positive PWID) and the HIV positive PWID.
Process of quantitative data collection and HIV testing
Before approaching the participants for interview and HIV testing, prior written consent was taken from the HIV positive PWID to include their female sex partners in the study. Thereafter, informed written consent (those who were 18 years of above) or assent (those who were below 18 years of age) was taken from the female sex partners of PWID followed by pre-test counselling according to the national HIV testing guidelines [14]. Written assent was taken from parents or guardians of the participants. The assent was read out to the participants and the parents/guardians, and their signature or left thumb print impression was taken on the survey form. After pre-test counselling, HIV test was done by OraQuick HIV test kit using Oral Fluid [15]. Thereafter, a face to face interview was held with the participants using a semi-structured questionnaire. All questions were asked in Bangla and interviewers were trained thoroughly. At the end of training sessions, all procedures related to the study such as obtaining written informed consent/assent, counselling (per and post), HIV testing using OraQuick HIV test kit, and risk behaviour interview was piloted outside of the Dhaka city. Experience from the field testing was used to fine-tune the quality of work and the questionnaire of measuring risk behaviours and vulnerabilities of the participants to enhance the validity of data and smooth running of the study. During the training, the importance of confidentiality and respect to the HIV positive PWID and their female sex partners was also emphasised. All interviews and HIV testing were held at Comprehensive Drop-in-Centres (DICs)/Drop-in-Centres (DICs) of the harm reduction program if the participant was able to come or at the residence of the participant where privacy and confidentiality could be maintained. HIV was tested using the OraQuick Rapid HIV Antibody test kit (OraSure Technologies, Inc. Bethlehem, PA 18015, USA) performed on Oral Fluid [15]. From those who’s test result was found reactive with the OraQuick, 5ml blood was taken for confirmatory test using serum based rapid HIV testing by three WHO-recommended rapid test kits at the Virology Laboratory in Dhaka following the national HIV testing algorithm [14]. While collecting blood samples, all aseptic precautions were maintained and sharps were disposed following standard universal precautions [16]. If any of the serum-based WHO-recommended rapid test result was HIV negative, then the sample was confirmed by Line Immune Assay (Western blot). After the HIV confirmatory test, the result was shared with the doctor/counsellor of CDIC/DIC of the implementing agencies for conducting post-test counselling and taking measures to initiate HIV treatment, care and support (TCS) services.
Timeline
Quantitative data were collected from June to November 2019 followed by data entry, analysis and report writing.
Definition of risk behaviours and vulnerabilities
In this manuscript, HIV risk behaviours refer to 1) drugs and injection-related risk behaviours and 2) sexual risk behaviours with male sex partners such as: husband, clients, and non-transactional male sex partners (boyfriends/relatives/neighbours). Vulnerabilities refer to 1) treatment of and knowledge of STIs and HIV; and 2) uptake of routine HIV testing and HIV prevention services by the NGOs; and 3) Physical/sexual violence and other vulnerabilities.
Definition of the comprehensive knowledge of HIV and measuring the progress of HIV testing services
The comprehensive knowledge of HIV was defined according to the UNAIDS [17] who simultaneously answered to five questions correctly such as, 1) “can people reduce their risk of HIV by using a condom correctly and consistently in any type of sex?” (correct answer is ‘yes’), 2) “can people reduce their risk of HIV by avoiding sex with multiple partners?” (correct answer is ‘yes’), 3) “can a person get HIV through mosquito bite?” (correct answer is ‘no’), 4) “can a person get HIV by sharing a meal with someone who is HIV infected?” (correct answer is ‘no’), and 5) “can you tell by looking at someone whether s/he is infected with HIV?” (correct answer is ‘no’). Progress of the HIV testing was also assessed according to the UNAIDS definition [17] such as, 1) “have you been tested for HIV in the last 12 months?” and 2) “if yes, I don’t want to know the results, but did you receive the results of that test?”
Data management and analysis
The laboratory data were entered by Excel for each participant with a unique key identification number. The HIV risk behaviours and vulnerability data were entered twice by Epi-Info (Version 3.5) with range and consistency checks. Data were further cleaned by Excel before analysis. The categorical variables were described in terms of percentage points and numeric variables by medians along with inter-quartile range (IQR). In this manuscript all participants were combined into one group who represent female sex partners of the HIV positive PWID in Dhaka city. Data were analysed using Stata (version 13) for 227 participants among whom (136 were wives, 66 FSW and 25 non-transactional female sex partners (girl-friends/relatives/neighbours) were combined into one group). Stata was also used to calculate 95% confidence interval (CI) for all categorical variables.
Ethical assurance
The study proposal was reviewed and approved by the Institutional Review Board, which consists of the research review committee (RRC) and ethical review committee (ERC).
Results
The target sample size in this study was 372 and finally, 227 (61.0%) were achieved. We faced challenges in interviewing FSWs and other female sex partners that have been mentioned in the challenges section. The study findings have been described below.
Socio-demographics
The majority of the participants (74.9%) were 25–49 years old with median age of 34.0 years (IQR: 27.0–41.0) (Table 1). A little more than half of the participants had no education. The median income in the last month was approximately 42 USD (IQR: 0–85) (1 USD = 94.7 Taka, according to Bangladesh Bank, August 06, 2022) [18]. Mostly (82.4%, 95% CI: 76.8–86.8) were currently married. The median age of participants at the time of marriage was 15.0 years (IQR: 13.0–18.0). The median age at the first sex act was 14.0 years (IQR: 12.0–16.0). At the same time, 18.9% (95% CI: 14.3–24.6) lived on the streets.
[Figure omitted. See PDF.]
Prevalence of HIV
The prevalence of HIV was 16.7% (38 out of 227, 95% CI: 12.4–22.2); 31 were (13.7%, 95% CI: 9.5–18.8) detected previously through the routine HIV testing by the NGOs and 7 (3.1%, 95% CI: 1.2–6.2) were newly detected by this study. Of the 38 HIV positive participants, 33 (86.8%, 95% CI: 71.9–95.6) were in the reproductive age group 15–49 years. Further analysis of data showed that of the seven newly identified HIV cases, two were aged 15–24, three were aged 25–34 and two were aged 35–49 years old. Among those who were currently married, 8 participants were pregnant at the time of survey; of them no one was found HIV positive. All previously identified HIV positive cases were on the anti-retroviral treatment (ART). Of the 7 newly identified HIV positive cases, 4 cases were enrolled into the ART and 3 were still not traced/lost to follow-up. Later, repeated initiatives were taken by the implementing agency to find out the participants who were traceless but they were not found.
HIV risk behaviours
Drugs and injection related risk behaviours.
One-fourth (24.7%, 95% CI: 19.5–30.7) of the participants reported had taken any kind of drugs in the last year (Table 2). Among them, 78.6% (95% CI: 65.5–87.6) reported Methamphetamine (locally known as Yaba) as the most frequent drugs followed by 69.6% (95% CI: 56.0–80.5) sleeping pills (such as, Noctin, Enoktin, Triptin, Sedil, Milam, Tanodil, etc), 58.9% (95% CI: 45.3–71.3) cannabis and 50% (95% CI: 36.8–63.2) injecting drugs. The median duration of taking any kind of drugs was reported at 11.0 years (IQR: 6.0–20.0). Among those who injected drugs in the last week, 14.3% (95% CI: 4.2–38.7) reported shared needles/syringes always and 38.1% (95% CI: 19.1–61.7) reported sometimes with husband/other male injecting drug users.
[Figure omitted. See PDF.]
Sexual risk behaviours with the male sex partners.
Among those who were currently married at the time of survey, sex with HIV positive husband in the last year was reported by 77% (95% CI: 71.0–82.1) of the participants (Table 3). In the last year, only 18.7% (95% CI: 13.5–25.3) reported consistent condom use during all sex acts and only 29.2% (95% CI: 22.9–36.6) used condom in the last sex act. Of 227 participants, 66 (29.1%, 95% CI: 23.3–35.4) were professional female sex workers (FSW). In the last year, consistent use of condoms was reported by only 15.2% (95% CI: 8.2–26.2) of the participants and the last time condom use in the last sex act with a client was reported by 43.9% (95% CI: 32.3–56.3). Approximately, one in every five participants (19.4%, 95% CI: 14.7–25.1) had sex with non-transactional male sex partners (except husband and clients) in the last year. Consistent use of condoms was reported by only 6.8% (95% CI: 2.1–19.9) and the last time condom use in the last sex act was reported by 22.7% (95% CI: 12.4–38.0) of the participants in the last year.
[Figure omitted. See PDF.]
Vulnerability to HIV
Treatment of and knowledge of the STIs and HIV.
Three in every four participants (75.3%, 95% CI: 69.2–80.8) did not have any knowledge on symptoms of sexually transmitted infections (STIs) (Table 4). Self-reported symptoms of any STIs, such as: i) painful or smelly discharge; or ii) lower abdominal pain which was not associated with menstruation, or a stomach upset; or iii) genital warts, sores, or ulcers, were reported by 26% (95% CI: 20.7–32.1) of the participants. A little more than half of the participants received treatment for STIs in the last year. Only 19.4% (95% CI: 14.7–25.1) had comprehensive knowledge of HIV.
[Figure omitted. See PDF.]
Uptake of the routine HIV testing and HIV prevention services providing by the NGOs
Approximately two-third of the study participants (67.4%, 95% CI: 61.0–73.2) reported that they knew about HIV testing through the NGOs (Table 5). Three in every five (61.7%, 95% CI: 55.1–67.8) study participants reported ever testing for HIV and 38.3% (95% CI: 32.2–44.9) mentioned never tested for HIV in their lifetime. Among those who never tested for HIV, participants mostly (87.4%, 95% CI: 78.4–92.9) mentioned ‘no one told me to test’. In the last year, as a routine HIV prevention services by the PWID Drop-in-Centres (DICs), 42.7% (95% CI: 36.4–49.3) received HIV testing services from the PWID DICs as a routine HIV prevention service and knew the result.
[Figure omitted. See PDF.]
In the last one year, 64.3% (95% CI:57.8–70.3) reported receiving any HIV prevention services from the CDICs/DICs (Table 5). On the other hand, approximately one-third of the participants never received any HIV prevention services. Among those who had received services in the last year, mostly mentioned received HIV testing and services (HTS) (90.4%, 95% CI: 84.4–94.3). Of those who received services in the last year, only 36.3% (95% CI: 28.8–44.5) of the participants mentioned received condoms.
Physical and sexual violence, and other vulnerabilities
The data on physical and sexual violence and other vulnerabilities showed that in the last year, 45.9% (95% CI: 39.3–52.6) participants reported been beaten and 20.2% (95% CI: 15.3–26.1) reported been raped (Table 6). Most of the episodes of beating and rape were perpetuated by the husbands (61–67%). Further analysis of data showed that out of 136 wives, 40 (29.4%, 95% CI: 22.3–37.7) reported been beaten within the last year. Of 40 wives, 34 (85.0%, 95% CI: 70.1–93.2) reported that they were beaten by their husband who is a HIV positive PWID. Of 136 wives, 13 (9.6%, 95% CI: 5.6–15.8) reported that they have been raped in the last year. Of them, everyone mentioned that they were raped by their husband who is a HIV positive PWID. FSWs and other female sex partners also reported that they were been beaten and raped by their husband who were non-PWID and the status of HIV infection of these husbands were not known. Among those who were ever married, 44.6% (95% CI: 38.1–51.2) knew that the husband injects drugs. Of those who sold sex (professional sex workers) in the last year, 56.1% (95% CI: 43.6–67.8) knew that their clients inject drugs and of those who had sex with non-transactional male sex partners in the last year, 54.5% (95% CI: 39.3–69.0) knew that their non-transactional male sex partners inject drugs.
[Figure omitted. See PDF.]
Discussion
The findings of this study revealed the characteristics, prevalence of HIV, risk behaviours and vulnerabilities among female sex partners of the HIV positive PWID in Dhaka city. This is the first of its kind of study in Bangladesh among these population groups, from which comprehensive quantitative data are available that can be useful to re-design or strengthen HIV prevention services for the studied population groups in Dhaka city.
The prevalence of HIV among the study participants was 16.7% which crossed the concentrated epidemic level 5% [19] and coincides (2.5%-45.0%) with the data from similar groups in Pakistan, India, Kazakhstan, Vietnam, Iran, Russia, Kyrgyzstan and Malaysia [3–10, 20]. On the other hand, the prevalence of HIV among the PWID (who were the husbands or male sex partners of this study participants) in Dhaka city was 22% in [1]. Studies conducted in Vietnam and Pakistan showed that the PWID male sex partners were one of the major sources of HIV infection among their female sex partners [21, 22]. Secondary analysis of data among 400 wives of the PWID in India showed that the wives were 17.9 times more likely to be infected with HIV if the PWID husbands were HIV infected (p<0.001) [20]. The sources of the HIV infection among the participants in this study can also be explained by the HIV case reporting data. The HIV case reporting data in Bangladesh showed that in 2020, 534 new HIV cases were detected, and of which 21% were female, 76% were male and 3% were hijra (transgender) [23]. The HIV case reporting data also showed that of 534 new HIV infections, 24.7% were PWID. Similar data from Iran in 2010 showed that 8.7% of 9,136 new HIV cases were detected among women, and of which, 76% of the women were infected by their husbands who were primarily PWID [24]. In this study, a large number of the participants (83.3%) were still HIV negative despite having sex with a HIV positive PWID. This may be because the HIV positive PWID are on the ART for a long period of time and they are virally suppressed therefore, are not transmitting HIV to their female sex partners [25]. However, a representative survey of the HIV viral load testing among the HIV positive PWID in Dhaka city is needed to be conducted to find out what percentage of the PWID are virally suppressed so that transmission of HIV to their female sex partners has become limited [26]. In this study, of a total of the 38 HIV positive participants, 31 (13.6%) were old cases identified before by the NGOs and 7 (3.1%) were newly identified in this study. Identification of the new HIV cases in this study was similar with a study conducted among 364 female sex partners of the PWID in Kazakhstan that detected only 19 participants (5.2%) who were newly infected with HIV [6].
Taking any kind of drugs was a common risk behaviour among the female sex partners of the PWID in other countries and we also found the same in our study which more closely reflects with estimates from similar population groups (16%-58%) in India, Iran, Vietnam and Pakistan [7, 20, 27, 28]. Among those who had taken drugs in the last year, Yaba and sleeping pills (such as, Noctin, Enoktin, Triptin, Sedil, Milam, Tanodil, etc) were the most popular. A study conducted among the HIV positive PWID in Vietnam showed that the use of methamphetamine may increase the likelihood of the HIV transmission from a HIV positive PWID to non-injecting female sexual partners due to its potential to decrease the ART adherence, which would consequently weaken the immune system and increase viral load [29]. Of 21 study participants who injected drugs during the last week, 11 (52.4%) reported shared needles/syringes always or sometimes with their husbands or other males that signals in addition to the sexual transmission, HIV infection may have been transmitted to them by sharing contaminated needles/syringes as was reported in a study among similar population in India [30]. The low rate of condom use (both during the last sex act and consistently) demonstrated that the female sex partners who were still HIV negative were at a great risk of HIV infection. Similar situation was observed among the female sex partners of the HIV positive PWID in Pakistan [4].
In this study, knowledge of the STI infection and treatment-seeking behaviour was poor. Similar findings were observed (9.9%-44.7%) among the women of the HIV positive PWID in India and Pakistan [3, 4]. Seeking treatment for the STIs was low by the participants in this study that indicates the unmet need for the STIs prevention and treatment for these population groups is urgent to reduce the risk of the HIV infection. The comprehensive knowledge of HIV was found very low (19.4%) among the study participants compared to 42.5% among similar participants in Pakistan [4]. The comprehensive knowledge of HIV was found significantly lower (p<0.001 for both comparisons) among the participants in this study compared to 41.5% general female population in Bangladesh [31] and 68% in Pakistan [32], respectively. A study conducted among the 15–49 ever-married women in Pakistan showed that the comprehensive knowledge of HIV was 1.25 times higher among the women who were exposed to the mass-media than those who were not exposed to the mass-media [32] that suggests providing the knowledge on HIV is urgently needed by the mass-media such as radio/TV/Social media/News paper in our country.
In this study, a considerable percentage of the participants were never tested for HIV due to lack of the designated field staff and in some DICs the participants live far away. Out of 227 sampled, 38.3% (n = 87) never tested for HIV that indicates they were hard to reach by the current HIV prevention services. Of them, mostly (87.4%) mentioned they were not aware of the HIV testing by the NGOs that demands immediate action. A study conducted in Vietnam among the female sex partners of the PWID showed that the HIV testing went up to 65% after 2 years of interventions from 37% at the baseline [33].
Findings in this study highlight that the services for these participants were available mostly for HIV testing and enrolled them into the ART when they were identified as HIV positive. At the same time, a promising result is that of the previously diagnosed HIV positive participants (n = 31), everyone was on the ART. A few of the participants mentioned that they received condoms (36.3%) or attended educational programs (22.6%) that signalled condom promotion was inadequate. On the other hand, approximately one-third of the participants never received any services due to the lack of the designated field staff. All these findings highlight that the HIV prevention program for these population groups need to be reviewed and then strengthened.
Targeted HIV prevention programmes have been implemented among key populations (KPs) who are at risk of HIV in Bangladesh since 1995 [34] and the harm reduction program for the people who inject drugs (PWID) started in Dhaka in 1998 [35]. Currently, the services are being provided by the NGOs through static CDICs/DICs and outreach workers in the drug-taking spots where PWID (both male and female) assemble to take drugs. The services include distribution of sterile needles/syringes, distribution of condoms and behaviour change communication (BCC) materials, CDIC/DIC based clinical services for managing abscess or injection related infections and STIs, HIV testing services (HTS), along with motivational education (one-to-one and in a group), provision of TB treatment, anti-retroviral treatment (ART) as per need and opioid substitution therapy (OST) [36]. Females who inject drugs (FWID) with suspected STIs found during syndromic diagnosis at the DICs are referred to the DICs of FSW for the STI management. They are also sent to the FSW DICs for other sexual and reproductive health services (SRH). There is an option for testing female partners of the HIV positive PWID at CDICs/DICs and if needed ART is provided to them. In addition, female sex partners of the HIV positive PWID are linked to the tertiary hospitals for pregnancy care, breastfeeding counselling and early infant diagnosis. However, it may be mentioned that testing HIV for female sex partners of the HIV positive PWID are being conducted on a limited scale. When our study was in a process of planning during February 2019, in total, till December 2018, only 19 wives of the HIV positive PWID were identified as HIV positive (personal communication with CARE Bangladesh).
Strengths, weaknesses and challenges
This study has several strengths, weaknesses and challenges. The first and foremost strength was that, this study demonstrated for the first time in Bangladesh the success of utilizing a network of the HIV positive PWID to access their female sex partners in identifying new cases of HIV and exploring detail information on socio-demographics, HIV risk behaviours and vulnerabilities who were otherwise difficult to reach by the current HIV prevention services alone [37]. Another strength of this study was the feasibility of using OraQuick rapid testing as a way of identifying new HIV cases among these participants. The limitations were, 1) behavioural information was collected through a face-to-face interview therefore, responses might have some social desirability bias [38], and 2) some information on drugs and sexual risk behaviours might suffer from recall bias [39].
During data collection we faced some challenges. Firstly, it was very challenging to take consent from the HIV positive PWID to get access to their female sex partners. Initially, they were very afraid that the study team would disclose his HIV status to his wife or his other female sex partner. When the study team spent some time explaining the objectives and benefits of this study, they agreed. Secondly, non-drug user female sex partners did not feel comfortable coming to the CDICs/DICs because at that time other injecting drug users were there and the place was crowded. Thirdly, some female sex partners lived far away from the CDICs/DICs. In that case, the team members went to their home and completed HIV testing and interview. The HIV positive PWID were not been able to identify the FSWs properly because the sex act was performed at night in many places with multiple FSWs during a period of time. Also, other female sex partners were reluctant to come to the CDICs/DICs or did not allow the team members to go to them due to the fear of being disclosed of her affair with an injecting drug user to the society/family. Due to these reasons, data collection against the sample sizes for FSWs and girl-friends/relatives/neighbours were not full-filled.
Recommendations
Based on the findings and discussions, we would like to recommend:
1. The HIV prevention programs targeted to the female sex partners of the HIV positive PWID in Dhaka city need to be reviewed to find out strengths and weaknesses, and need more attention from the relevant stake holders.
2. Existing HIV prevention services for the HIV positive PWID should also include components for their female sex partners [40, 41] such as condom distribution and promotion, and educational program.
3. Counselling of couples need to be ensured. A study conducted among 4,612 female regular sex partners of the PWID in Bangladesh, Bhutan, India, Nepal and Sri Lanka showed that women who were approached and counselled by the service providers with information on HIV/AIDS, were 1.7 times (95% CI: 1.4–2.0) more likely to use condoms in the last sex act with their PWID sex partners [41]. Therefore, the HIV positive PWID can be encouraged to bring their female sex partners into a CDIC/DIC for couple counselling in a particular time slot [30]. Counselling of influential family members such as father/mother/in-laws is also needed to make an enabling environment to provide services to these population groups [42].
4. Female sex partners of the HIV positive PWID who are still HIV negative need to be tested preferably six monthly or at least once a year [14] for early detection of HIV and early initiation to the ART that can play an important role in controlling the epidemic.
5. Initiatives needed to be taken to improve the knowledge related to HIV/STI among the study participants by developing information materials that are easily understandable and preferably delivered by female workers/staff [4]. Studies in the Northern India showed that due to the lack of female workers in the DICs, PWID do not want to bring their wives to take services [30]
6. Utilization of treatment for the STIs can be further increased by appointing female doctors/Medical Assistants from the nearby DICs where the participants live so that she can be followed-up to ensure access and utilization of services routinely [30]
7. A representative survey of the HIV viral load testing among the HIV positive PWID in Dhaka city is urgently needed to be conducted to find out what percentage of them are virally suppressed that limits the transmission of HIV to their female sex partners [26]
Conclusion
The findings of this manuscript highlight that the needs of the female sex partners of the HIV positive PWID have never been effectively identified and met. Therefore, it is urgently necessary to consider the high-risk behaviours, vulnerabilities, and challenges in designing or to strengthen targeted interventions for female sex partners of the HIV positive PWID in Dhaka city to ensure equality in access and utilization of services.
Supporting information
S1 File.
https://doi.org/10.1371/journal.pone.0286673.s001
S2 File.
https://doi.org/10.1371/journal.pone.0286673.s002
Acknowledgments
First of all, we would like to express our gratitude to the HIV positive PWID in Dhaka city for providing their consent allowing us to interview their female sex partners in this study. We also thank female participants who provided blood and giving their time in responding to questions. Without their active participation the survey would not have been possible and they are therefore acknowledged gratefully. We are thankful to the Save the Children International Bangladesh and CARE Bangladesh allowing us using their comprehensive drop-in-centres (CDICs)/ drop-in-centres (DICs) for data collection venue. We also thank all staff members in the CDICs/DICs for their cordial co-operation in recruiting participants. We thank Mr. Abu Taher for his constant supervision in data collection. We are grateful to AIDS/STD programme (ASP) for overall support, coordination and monitoring of the field activities.
Citation: Reza MM, Rana AKMM, Morshed Khan MN, Safiullah Sarker M, Chowdhury S, Uddin MZ, et al. (2023) Prevalence of HIV, risk behaviours and vulnerabilities of female sex partners of the HIV positive people who inject drugs (PWID) in Dhaka city, Bangladesh. PLoS ONE 18(6): e0286673. https://doi.org/10.1371/journal.pone.0286673
About the Authors:
Md. Masud Reza
Roles: Conceptualization, Data curation, Formal analysis, Methodology, Project administration, Resources, Supervision, Validation, Writing – original draft, Writing – review & editing
Affiliation: Programme for HIV and AIDS, Infectious Disease Division, International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b), Dhaka, Bangladesh
A. K. M. Masud Rana
Roles: Conceptualization, Supervision, Validation, Writing – original draft, Writing – review & editing
Affiliation: Programme for HIV and AIDS, Infectious Disease Division, International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b), Dhaka, Bangladesh
Mohammad Niaz Morshed Khan
Roles: Supervision, Writing – review & editing
Affiliation: Programme for HIV and AIDS, Infectious Disease Division, International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b), Dhaka, Bangladesh
Md. Safiullah Sarker
Roles: Supervision, Writing – review & editing
Affiliation: Programme for HIV and AIDS, Infectious Disease Division, International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b), Dhaka, Bangladesh
Sujan Chowdhury
Roles: Supervision, Writing – review & editing
Affiliation: Programme for HIV and AIDS, Infectious Disease Division, International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b), Dhaka, Bangladesh
Md. Ziya Uddin
Roles: Writing – review & editing
Affiliation: HIV/AIDS Specialist, UNICEF, Dhaka, Bangladesh
Lima Rahman
Roles: Writing – review & editing
Affiliation: Director, Health and Nutrition Sector, Save the Children in Bangladesh, Dhaka, Bangladesh
Mohammad Ezazul Islam Chowdhury
Roles: Supervision, Writing – review & editing
Affiliation: Technical Advisor, HIV/AIDS Program, Save the Children in Bangladesh, Dhaka, Bangladesh
Md. Abu Taher
Roles: Supervision, Writing – review & editing
Affiliation: National Programme Coordinator (Drugs and HIV/AIDS), UNODC, Dhaka, Bangladesh
Sharful Islam Khan
Roles: Conceptualization, Project administration, Resources, Supervision, Validation, Writing – review & editing
E-mail: [email protected]
Affiliation: Programme for HIV and AIDS, Infectious Disease Division, International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b), Dhaka, Bangladesh
ORICD: https://orcid.org/0000-0002-7319-1333
1. AIDS/STD Programme (ASP). Behavioural and Serological surveillance amongst key populations at risk of HIV in selected areas of Bangladesh 2016 Dhaka, Bangladesh: Directorate General of Health Services (DGHS), Ministry of Health and Family Welfare, Government of the People’s Republic of Bangladesh; 2017. Available from: http://asp.portal.gov.bd/sites/default/files/files/asp.portal.gov.bd/page/4129b6d9_3565_48d5_8f89_ef37abb51732/2020-08-10-22-53-441586ce07ccd5e787b792da60812279.pdf.
2. Solomon S, Subbaraman R, Solomon SS, Srikrishnan AK, Johnson SC, Vasudevan CK, et al. Domestic violence and forced sex among the urban poor in South India: implications for HIV prevention. Violence against women. 2009;15(7):753–73. https://doi.org/10.1177/1077801209334602. pmid:19448166
3. Panda S, Chatterjee A, Bhattacharya SK, Manna B, Singh PN, Sarkar S, et al. Transmission of HIV from injecting drug users to their wives in India. International journal of STD & AIDS. 2000;11(7):468–73. https://doi.org/10.1258/0956462001916137. pmid:10919490
4. Shahid S, Majeed MF, Awaan AB, Mirza H, Sarfraz N, V V. Expanding access to HIV testing and counseling and exploring vulnerabilities among spouses of HIV-positive men who inject drugs in Pakistan. Current Opinion in HIV and AIDS. 2016;11(Suppl 1):S6. pmid:26945140
5. Hammett TM, Phan S, Nguyen P, Kieu B, Dang S, Nguyen D, et al. Female sexual partners of male people who inject drugs in Vietnam have poor knowledge of their male partners’ HIV status. JAIDS Journal of Acquired Immune Deficiency Syndromes. 2015;68(5):562–7. pmid:25559591
6. Nabila El-B, Louisa G, Assel T, Elwin W, Chris B, Stacey S, et al. HIV among injection drug users and their intimate partners in Almaty, Kazakhstan. AIDS and Behavior. 2013;17(7):2490–500. https://doi.org/10.1007/s10461-013-0484-2. pmid:23612942
7. Alipour A, Haghdoost AA, Sajadi L, F Z. HIV prevalence and related risk behaviours among female partners of male injecting drugs users in Iran: results of a bio-behavioural survey, 2010. Sexually transmitted infections. 2013;89(Suppl 3):iii41–iii4. https://doi.org/10.1136/sextrans-2013-051201. pmid:24064986
8. Deryabina AP, Patnaik P, El-Sadr , M W. Underreported injection drug use and its potential contribution to reported increase in sexual transmission of HIV in Kazakhstan and Kyrgyzstan. Harm reduction journal. 2019;16(1):1–6. https://doi.org/10.1186/s12954-018-0274-2. pmid:30611251
9. Eritsyan KU, Levina OS, White E, Smolskaya TT, R H. HIV prevalence and risk behavior among injection drug users and their sex partners in two Russian cities. AIDS research and human retroviruses. 2013;29(4):687–90. https://doi.org/10.1089/aid.2012.0161. pmid:23186172
10. Manaf R. A brief report on HIV risk and preventive behaviours among the intimate partners of men who inject drugs in Kuala Lumpur & Selangor: University of Otago; 2015. Available from: https://www.researchgate.net/publication/285120103_A_brief_report_on_HIV_risk_and_preventive_behaviours_among_the_intimate_partners_of_men_who_inject_drugs_in_Kuala_Lumpur_Selangor.
11. Lemeshow S HD, Klar J, Lwanga SK,. Adequacy of sample size in health studies: Wiley, Chichester; 1990.
12. Kish L. Survey sampling. New York: J. Wiley; 1965. 643 p.
13. Save the Children Bangladesh. In Depth Review of the PWID Intervention to Identify Strategies for Quality HIV/AIDS Services and Increased Coverage: External review report. Report prepared by Tasnim Azim and Gary Reid. 2018.
14. National AIDS/STD Programme (NASP). National HIV Testing Services (HTS) Guideline Dhaka, Bangladesh: Directorate General of Health Services, Ministry of Health and Family Welfare, Government of the People’s Republic of Bangladesh; 2019. Available from: http://asp.portal.gov.bd/sites/default/files/files/asp.portal.gov.bd/page/2d04f70c_c5e5_4d3d_9a13_e8cc7e5af9c9/2020-10-13-15-08-4a1e3ea20e31310a8d86f2512d8a933c.pdf.
15. Nkenfou CN, Kembou JE, Temgoua ES, Djikeng A, Mouafo LM, Ndzie EN, et al. Evaluation of OraQuick® HIV-1/2 as oral rapid test. African journal of infectious diseases. 2013;7(2):27–30. pmid:28451078
16. Richmond JY. HIV biosafety: guidelines and regulations: Springer; 1994. 346–60]. Available from: https://link.springer.com/chapter/10.1007/978-1-4612-0867-9_22.
17. UNAIDS. Monitoring the Declaration of Commitment on HIV/AIDS, GUIDELINES ON CONSTRUCTION OF CORE INDICATORS, 2010 Reporting 2009. Available from: https://data.unaids.org/pub/manual/2009/jc1676_core_indicators_2009_en.pdf.
18. Government of Bangladesh (GoB). Exchange rate of Taka into United states Dollar 2021 [cited 2021 May 18]. Available from: https://www.bb.org.bd/en/index.php.
19. World Health Organization (WHO). Guidelines for second generation HIV surveillance: An update: Know your epidemic 2013. Available from: https://apps.who.int/iris/bitstream/handle/10665/85511/9789241505826_eng.pdf.
20. Solomon SS, Srikrishnan AK, Celentano DD, Johnson SC, Vasudevan CK, Murugavel KG, et al. The intersection between sex and drugs: a cross-sectional study among the spouses of injection drug users in Chennai, India. BMC Public Health. 2011;11:1–10. pmid:21199570
21. Nadol P, Tran H., Hammett T., Phan S., Nguyen D., Kaldor J., et al. High HIV prevalence and associated risk factors among female sexual partners of male injection drug users (MWID) in Ho chi minh city, Vietnam. AIDS and Behavior. 2016;20(2):395–404. https://doi.org/10.1007/s10461-015-1156-1. pmid:26271814
22. Raees MA, Abidi SH, Ali W, Khanani MR, Ali S. HIV among women and children in Pakistan. Trends in microbiology. 2013;21(5):213–4. https://doi.org/10.1016/j.tim.2012.12.005. pmid:23648136
23. AIDS/STD Programme (ASP). World AIDS Day 2020: HIV/AIDS Situation in Bangladesh, Presentation slides by Prof. Dr. Md. Shamiul Islam, Director (MBDC) & Line Director, TB-L & AIDS/STD Programme, Directorate General of Health Services (DGHS), Gov of the People’s Republic of Bangladesh 2020. Available from: http://asp.portal.gov.bd/site/page/c497e315-340f-46a2-9cbd-d9e9c5c3d5ea/-.
24. Karamouzian M, Haghdoost AA, Sharifi H. Addressing the needs of sexual partners of people who inject drugs through peer prevention programs in Iran. International journal of health policy and management. 2014;2(2):81–3. pmid:24639982
25. World Health Organization (WHO). Surveillance of HIV drug resistance in adults receiving ART (acquired HIV drug resistance): Geneva: World Health Organization; 2014. Available from: http://apps.who.int/iris/bitstream/handle/10665/112801/9789241507073_eng.pdf?sequence=1.
26. Eisinger RW, Dieffenbach CW, AS F. HIV viral load and transmissibility of HIV infection: undetectable equals untransmittable. Jama. 2019;321(5):451–2. pmid:30629090
27. Hammett TM, Van NTH, Kling R, Binh KT, KTH O. Female sexual partners of injection drug users in Vietnam: an at-risk population in urgent need of HIV prevention services. AIDS care. 2010;22(12):1466–72. https://doi.org/10.1080/09540121003758580. pmid:21154034
28. Ahmad S, Mehmood J, Awan AB, Zafar ST, Khoshnood K, AA K. Female spouses of injection drug users in Pakistan: a bridge population of the HIV epidemic? EMHJ-Eastern Mediterranean Health Journal. 2011;17(4):271–6. https://apps.who.int/iris/handle/10665/118115. pmid:22259883
29. Feelemyer J, Duong TH, Khuê PM, Hoang TG, Thi TTN, Thi HOK, et al. Increased methamphetamine use among persons who inject drugs in Hai Phong, Vietnam, and the association with injection and sexual risk behaviors. Journal of psychoactive drugs. 2018;50(5):382–9. https://doi.org/10.1080/02791072.2018.1508790. pmid:30183558
30. Chakrapani V. Access to comprehensive package of services for injecting drug users and their female sex partners: Identification and ranking of barriers in Northeast India 2012. Available from: https://www.unodc.org/documents/southasia/publications/research-studies/NE_final_for_web_02-07-12.pdf.
31. National Institute of Population Research and Training (NIPORT). Bangladesh Demographic and Health Survey: Directorate General of Health Services, Ministry of Health and Family Welfare, Government of the People’s Republic of Bangladesh; 2014. Available from: https://dhsprogram.com/pubs/pdf/FR311/FR311.pdf.
32. Iqbal S, Maqsood S, Zafar A, Zakar R, Zakar MZ, F F. Determinants of overall knowledge of and attitudes towards HIV/AIDS transmission among ever-married women in Pakistan: evidence from the Demographic and Health Survey 2012–13. BMC public health. 2019;19(1):793. https://doi.org/10.1186/s12889-019-7124-3. pmid:31226969
33. Hammett TM, Kling R, Van NTH, Son DH, Binh KT, KTH O. HIV prevention interventions for female sexual partners of injection drug users in Hanoi, Vietnam: 24-month evaluation results. AIDS and Behavior. 2012;16(5):1164–72. https://doi.org/10.1007/s10461-011-0062-4. pmid:22016330
34. Azim T, Khan SI, Nahar Q, Reza M, Alam N, Saifi R, et al. 20 years of HIV in Bangladesh: experiences and way forward: World Bank; 2009. Available from: https://openknowledge.worldbank.org/bitstream/handle/10986/27592/643620WP0Bangl00Box0361535B0PUBLIC0.pdf?sequence=1&isAllowed=y.
35. Azim T, Chowdhury EI, Reza M, Faruque MO, Ahmed G, Khan R, et al. Prevalence of infections, HIV risk behaviors and factors associated with HIV infection among male injecting drug users attending a needle/syringe exchange program in Dhaka, Bangladesh. Substance use & misuse. 2008;43(14):2124–44. https://doi.org/10.1080/10826080802344583. pmid:19085439
36. Government of Bangladesh (GoB). Funding request application form submitted to the Global Fund for funding Dec 2017-Nov 2020: Directorate General of Health Services, Ministry of Health and Family Welfare, Government of the People’s Republic of Bangladesh; 2017. Available from: https://dghs.gov.bd/images/docs/Notice/Notice_12_02_2017.pdf.
37. El-Bassel N, Gilbert L, Terlikbayeva A, Beyrer C, Wu E, Shaw SA, et al. HIV risks among injecting and non-injecting female partners of men who inject drugs in Almaty, Kazakhstan: implications for HIV prevention, research, and policy. International Journal of Drug Policy. 2014;25(6):1195–203. https://doi.org/10.1016/j.drugpo.2013.11.009. pmid:24556208
38. Catania JA, Gibson DR, Chitwood DD, TJ C. Methodological problems in AIDS behavioral research: influences on measurement error and participation bias in studies of sexual behavior. Psychological bulletin. 1990;108(3):339. https://psycnet.apa.org/buy/1991-07628-001. pmid:2270232
39. O’Sullivan LF. Challenging assumptions regarding the validity of self-report measures: the special case of sexual behavior. 2008. https://doi.org/10.1016/j.jadohealth.2008.01.002.
40. United Nations Office on Drugs and Crime (UNODC). Rapid Situation and Response Assessment (RSRA) of HIV/AIDS related risk behaviours, adverse health consequences, knowledge and attitudes relating to HIV/AIDS amongst drug users and their regular sex partners in Bangladesh, Bhutan, India, Nepal and Sri Lanka, A Regional Report: DFID and AusAID; 2008. Available from: https://www.aidsdatahub.org/sites/default/files/resource/rapid-situation-and-response-assessment-drugs-and-hiv-bangladesh-bhutan-india-and-sri-lanka.pdf.
41. Kumar MS, Virk HK, Chaudhuri A, Mittal A, G L. A rapid situation and response assessment of the female regular sex partners of male drug users in South Asia: factors associated with condom use during the last sexual intercourse. International Journal of Drug Policy. 2008;19(2):148–58. https://doi.org/10.1016/j.drugpo.2007.12.003. pmid:18221862
42. Malik M, Jamil MS, Johnson CC, Pasha MS, J H. Integrating assisted partner notification within HIV prevention service package for people who inject drugs in Pakistan. Journal of the International AIDS Society. 2019;22(Suppl Suppl 3). pmid:31321894
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
© 2023 Masud Reza et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Abstract
Background
The HIV epidemic in Bangladesh is largely being driven by people who inject drugs (PWID) and mainly concentrated in Dhaka city. Intregrated biological and behavioural survey (IBBS) data of 2016 showed that a considerable percentage of the HIV positive PWID had unsafe sex with their female sex partners. Prevalence of HIV, risk behaviorus and vulnerabilities among the female sex partners of the PWID still remain unexplored.
Methods
To measure HIV prevalence, risk behaviours (drugs/injection/sexual) and vulnerabilities (treatment of and knowledge of sexually transmitted infections (STIs) and HIV/uptake of the routine HIV testing and HIV prevention services/physical and sexual violence), a quantitative survey was conducted among 227 female sex partners of the HIV positive PWID in Dhaka city in 2019 by adopting a take-all sampling technique.
Results
The median age of participants was 34.0 years. Prevalence of HIV was 16.7% (95% CI: 12.4–22.2). Only 6.8% to 18.7% of the participants used condoms consistently with different male sex partners; only 6.8%cto 18.7% during last year. Seventy five percent (95% CI: 69.2–80.8) had no knowledge on STI symptoms. Self-reported symptoms of STIs were reported by 26% (95% CI: 20.7–32.1) and half sought treatment during last year. Nineteen percent (95% CI: 14.7–25.1) had comprehensive knowledge of HIV. As part of the routine HIV prevention services by the PWID drop-in-centres (DICs), 42.7% (95% CI: 36.4–49.3) of the participants were tested for HIV and knew their result within the last year. One-third never received HIV prevention services. During the last one year preceding the survey, 46% (95% CI: 39.3–52.6) reported been beaten and 20.2% (95% CI: 15.3–26.1) been raped.
Conclusion
It is urgently necessary to consider the high-risk behaviours and vulnerabilities in designing or to strengthen targeted interventions for female sex partners of the HIV positive PWID in Dhaka city to ensure equality in accessing and utilization of services.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer